Education
About Us
Working with TipRanks
Follow Us
MapLight Therapeutics, Inc. (MPLT)
NASDAQ:MPLT
Ml-007C-Ma
Psychosis Associated With Alzheimer's Disease
Phase II
Recruiting
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
Mar 14, 2025
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does MapLight Therapeutics, Inc. (MPLT) have in its pipeline
MPLT is currently developing the following drugs: Ml-007C-Ma, Ml-004 (Ir)/(Er) Tablet. These drug candidates are in various stages of clinical development as the company works toward FDA approval.